Global Mentorship Program for innovators in the oncology sphere, one step for a cancer-free future

In times of crisis, it’s natural to shift the focus to the matter that requires our attention the most. However, it’s crucial that we don’t abandon the areas that affect the lives of millions. Cancer is one of today’s biggest challenges and a myriad of researchers are working towards the common goal to find solutions for patients suffering from it. Here at cLAB Ventures, we support these innovators even in these turbulent times.

The 100% virtual Global Mentorship Programme was designed to help oncology innovations accelerate, scale and get funded. 


Blog_post_global_mentoring_program_cover_image

Many promising solutions are born in the fight against cancer, however, most of them fail due to the lack of skills and commercial support. The cLAB Ventures Online Mentorship Programme is a four-month virtual acceleration that helps early-stage companies to overcome barriers to get to market and become accessible to patients as soon as possible.

The programme is for entrepreneurs and startups developing solutions in the oncology sphere who are ready to scale. 10 startups will get a chance to participate in the Mentorship Programme, learn from top biotech professionals and business experts, join a global network and take their businesses to the next level.

The programme consists of:

  • Workshops – 7 modules including Sales management, Fundraising, Brand building, Customer validation
  • 1-to-1 Mentoring sessions – matching the startups with relevant mentors
  • Funding opportunities – introductions to life-science investors from around the world
  • Networking – access to our global network of accelerators, VCs, governmental organisations and research institutions

The programme will end in an online pitch day, where the participating startups will get the opportunity to present in front of investors and corporates. To read more about the programme follow the link: https://clabventures.com/mentorship-programme/

cLAB Ventures - July 24, 2020